This site is intended for Healthcare professionals only.

Natco Pharma gets EIR from USFDA for Kothur facility


Natco Pharma gets EIR from USFDA for Kothur facility

New Delhi: Drug firm Natco Pharma on Friday said it has received establishment inspection report (EIR) from the US health regulator for its Kothur facility in Telangana after successful completion of inspection.

Natco Pharma announces successful EIR from the US Food and Drug Administration (USFDA) for the inspection conducted at its drug manufacturing facility in Kothur village in Mahabubnagar district during January 16 24, 2017, the company said in a BSE filing on Thursday.

“The Kothur facility predominantly caters to regulated international markets, including USA,” it added.

EIR is given to an establishment after completion of inspection by the USFDA.



Source: PTI
0 comment(s) on Natco Pharma gets EIR from USFDA for Kothur facility

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted